Shield Therapeutics shares pressured by legal worries

0 mins. to read
Shield Therapeutics shares pressured by legal worries
Master Investor Magazine

Never miss an issue of Master Investor Magazine – sign-up now for free!

Read the latest Master Investor Magazine

AIM-listed pharmaceutical firm Shield Therapeutics (LON:STX) has seen its share price drop by 3.55% to 109.55p (as of 13:05 BST) after legal proceedings were lodged against it. Teva Pharmaceuticals has filed an appeal to the Opposition Division of the European Patent Office regarding the decision on a patent held by Shield.

Management said that the company will defend its intellectual property and believe that the board of appeal should uphold the original decision.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *


Get real investment insights from some of the best minds in the business - with our free Master Investor Magazine.